LATEST

• BUSINESS Forxiga Generics Reach 11% Share in First Month: Intage
  January 16, 2026

• REGULATORY Expert Calls for Full Verification of CEA Guidelines and Analytical Frameworks
  January 16, 2026

• BUSINESS Takeda to Halt Sales of Cell Therapy Alofisel in Japan
  January 15, 2026

• REGULATORY Japan Sets New Pricing Rules for Conditionally Approved Regenerative Medicines, Starting with Elevidys
  January 15, 2026

• BUSINESS Rohto to Roll Out 3- or 4-Day Workweek Option from April to Spur Growth, Retention
  January 15, 2026

• BUSINESS Rakuten Joins Hands with LOTTE Biologics to Boost Production for Photoimmunotherapy
  January 15, 2026

• ACADEMIA Japan’s Maternal RSV Vaccine Uptake at 11.6%, Survey Finds
  January 15, 2026

• BUSINESS Daiichi Sankyo Unveils Brand Site for OTC NorLevo Ahead of Launch
  January 15, 2026

• BUSINESS Cheplapharm to Take Over Japan MA for UCB’s Myocalm
  January 15, 2026

• BUSINESS Meiji-Daito Generic Consortium Expands to Eight Members
  January 15, 2026

• BUSINESS Daiichi Launches PIII Datroway Trial in TROP2 Positive NSCLC
  January 15, 2026

• BUSINESS Opdivo-Yervoy Combo Expands Label for Colorectal Cancer in Taiwan: Ono
  January 15, 2026

• ORGANIZATION Pharma FTC Clarifies “Simple Beverages” under New Food Rules
  January 14, 2026

• BUSINESS UK Fund AVI Raises Stake in Wakamoto Above 10%
  January 14, 2026

• REGULATORY MHLW Orders Label Revisions for Aspirin, CAR-T Therapies, and Other Drugs
  January 14, 2026

• REGULATORY Japan to Stick with 7 New Drug Approval Rounds a Year
  January 14, 2026

• BUSINESS Eisai Picks Up Rights to Nuvation’s Taletrectinib in Europe, Other Regions
  January 14, 2026

• BUSINESS Ono’s Colorectal Cancer Med Braftovi Widens Label in South Korea
  January 14, 2026

• BUSINESS Nxera Snags US$3.6 Million Early-Stage Milestone on OX2R Agonist
  January 14, 2026

• BUSINESS Gla-Alpha Launched in Singapore via Kowa: DWTI
  January 14, 2026

ページ

• « 先頭
• ‹ Prev
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »